Rocket Lab's Defining Quarter: Can a Record Order Book Outweigh a Halved Share Price?
Published on 08/03/2026 at 19:50 | Redaktion boerse-global.de
The numbers tell two very different stories about Rocket Lab right now. One is a company firing on all cylinders — a record $266 million Pentagon contract, a backlog stretching past 70 missions, and a transformation into a vertically integrated space infrastructure player. The other is a stock that has shed more than half its value since May, with a balance sheet still burning through cash at an alarming clip.
Investors get the next chapter on August 10, when the company reports second-quarter earnings. The stakes could hardly be higher.
A Stock in Freefall, a Business in Overdrive
The market's mood has soured dramatically. The shares, which traded around €56.90 in pre-market trading on Monday — up a modest 1.07 percent — have fallen 36.14 percent over the past 30 days alone. From the 52-week high of €133.80 reached in late May, the stock now sits 57.47 percent lower. Monday's 6.75 percent bounce to €60.10 offered some relief, but it does little to mask the scale of the recent sell-off.
What makes the decline particularly striking is that it has unfolded while the company's commercial momentum has never looked stronger. The valuation, even after the correction, remains demanding: analysts had the shares trading at roughly 57 times revenue. That's a rich multiple for a business that, on a trailing twelve-month basis, burned through $316 million in free cash flow — a negative FCF margin of 46.5 percent.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The first quarter of 2026 offered a glimpse of the growth trajectory: revenue of $200.3 million, up 63.5 percent year over year, with a gross margin of 38.2 percent. The order book stood at $2.2 billion. For the upcoming second-quarter report, consensus estimates point to revenue of $231.6 million and a loss of $0.06 per share.
The Pentagon Keeps Writing Checks
For investors looking past the share-price turbulence, the defense pipeline offers plenty of substance. On July 27, Rocket Lab landed the largest single contract in its history: $266 million from the U.S. Space Force for twelve guaranteed suborbital launches under the MACH-TB 2.0 program, with options for six more. The missions, slated to run through 2028 from Kodiak, Alaska, with the first launch no earlier than late 2026, will test missile defense systems for the Pentagon and the Missile Defense Agency. CEO Peter Beck's terse response: "Cadence, iteration, and relentless execution."
That award extends a remarkable run of government wins. Add in $816 million for 18 missile-warning satellites, $515 million for missile-defense satellites, $190 million for 20 hypersonic test flights using the HASTE vehicle — which has a perfect flight record beyond Mach 5 since 2023 — and the company's first GEO satellite contract worth $89.5 million for the Space Force. First-quarter sales alone nearly matched the entire prior year's total.
The Iridium Bet: A Pivot With a Price Tag
The strategic centerpiece, however, is the binding agreement to acquire Iridium Communications. The multi-billion-dollar deal marries Rocket Lab's rocket and satellite manufacturing with Iridium's low-Earth-orbit satellite network and L-band spectrum, creating a vertically integrated operator that controls both ends of the value chain. The logic is straightforward: pure launch providers struggle with lumpy project revenue and heavy capital costs, while Iridium brings millions of active subscribers and recurring, high-margin revenue. That combination could offer a faster route to operating profitability and positive free cash flow than traditional launch operators enjoy.
But the transaction — valued at $8 billion, with a cash component of $27 per share and backed by a $3.6 billion bridge facility — adds meaningful leverage to a balance sheet that is already under strain. The market's skepticism on that front is palpable.
Neutron: The Technical Heart, Still Waiting
Beneath the financial engineering sits the technical linchpin: the Neutron rocket. Its debut has slipped repeatedly. After a tank rupture in January, the first launch slipped to this year, and more recent assessments point to the fourth quarter of 2026. Beck has insisted the company will fly "when it's ready," prioritizing quality over schedule.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
There are encouraging signs. The Archimedes engine completed its qualification tests, and a full-duration hot fire ran for roughly 5.5 minutes at 1.5 million pounds of thrust — a figure Rocket Lab says is comparable to SpaceX's Merlin 1D. The "Hungry Hippo" fairing, which remains attached to the first stage, is designed to enable rapid reuse, a critical element in driving down launch costs.
Wall Street's Wide Divide
The analyst community is split on where the stock goes from here. Piper Sandler downgraded the shares to "Neutral" in mid-July, triggering an 11.7 percent single-day drop. At the optimistic end, Morgan Stanley's bull case targets $293, while the broader consensus leans "Strong Buy" with price targets ranging from $120 to $170. The average analyst target translates to roughly €99.37 — a 65.3 percent premium to current levels — suggesting the market has yet to fully price in the business-model transformation.
Adding to the debate: Beck recently sold around three million of his own shares, a move that will likely keep the valuation question front and center until the August 10 earnings call. With a market capitalization of approximately $35.11 billion, Rocket Lab has clearly outgrown its speculative start-up phase. The question now is whether it can prove — through Neutron's debut, Iridium's integration, and the path to profitability — that the whole is worth more than the sum of its parts.
Ad
Rocket Lab Stock: New Analysis - 3 August
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
